Hamilton Wealth’s AstraZeneca AZN Stock Holding History

Hamilton Wealth’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$633K	Sell	3,209 -30	-0.9%	-$5.79K	0.12%	62
2025 Q4	$596K	Buy	3,239 +459	+17%	+$80.5K	0.11%	68
2025 Q3	$427K	Buy	2,780 +1,182	+74%	+$179K	0.09%	72
2025 Q2	$223K	Hold	1,598	–	–	0.05%	93
2025 Q1	$235K	Buy	+1,598	New	+$231K	0.06%	92
2023 Q3	–	Sell	-2,612	Closed	-$374K	–	90
2023 Q2	$374K	Buy	2,612 +44	+2%	+$6.47K	0.13%	60
2023 Q1	$356K	Buy	+2,568	New	+$346K	0.13%	61
2020 Q4	–	Sell	-16,919	Closed	-$1.85M	–	53
2020 Q3	$1.85M	Buy	+16,919	New	+$1.88M	1.04%	36

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Hamilton Wealth's AZN Position: Q1 2026 in Review

Hamilton Wealth reduced its AstraZeneca (AZN) stake by 0.93% in Q1 2026, selling an estimated $5.79K and leaving 3,209 shares worth $633K. The position accounts for 0.12% of the portfolio, ranked #62.

Hamilton Wealth first reported a position in AZN in Q3 2020 and has held it in 8 quarters since. The position peaked at $1.85M in Q3 2020. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Hamilton Wealth held 3,209 shares of AstraZeneca worth $633K as of Q1 2026.
Hamilton Wealth sold 30 AstraZeneca shares in Q1 2026, an estimated $5.79K.
AstraZeneca made up 0.12% of Hamilton Wealth's portfolio in Q1 2026, its #62 holding.
Hamilton Wealth first reported a position in AstraZeneca in Q3 2020 and has held it in 8 quarters since.
Hamilton Wealth's AstraZeneca position peaked at $1.85M in Q3 2020.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Hamilton Wealth's 13F filing for Q1 2026, filed 18 May 2026.